The wide diversity and complexity of peptides bound to class II MHC molecules.

The identification and quantitation of peptides selected by class II MHC molecules during natural processing of proteins is of key importance in understanding the repertoire and distribution of T cells. The examination of peptides selected by class II MHC molecules has depended greatly on mass spectrometry, a powerful technique that identifies and sequences peptides in complex mixtures with great sensitivity and precision. Such analysis has resulted in the identification of several factors, including the repertoire of peptides selected by MHC molecules during natural processing of proteins, motifs important for selection of processed peptides, conformational isomers of peptide-MHC complexes, and post-translational changes to the peptides.

[1]  James J Walters,et al.  Natural peptides selected by diabetogenic DQ8 and murine I-A(g7) molecules show common sequence specificity. , 2005, The Journal of clinical investigation.

[2]  H. Rammensee,et al.  Identification of a naturally processed cyclin D1 T‐helper epitope by a novel combination of HLA class II targeting and differential mass spectrometry , 2004, European journal of immunology.

[3]  G. Pruijn,et al.  Citrullination: a small change for a protein with great consequences for rheumatoid arthritis , 2000, Arthritis research.

[4]  A. Hill,et al.  Naturally processed peptides from two disease-resistance-associated HLA-DR13 alleles show related sequence motifs and the effects of the dimorphism at position 86 of the HLA-DR beta chain. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[5]  E. Ward,et al.  T Cell Recognition of Distinct Peptide:I-Au Conformers in Murine Experimental Autoimmune Encephalomyelitis 1 , 2003, The Journal of Immunology.

[6]  H. Birnboim,et al.  Cutting Edge: MHC Class II-Restricted Peptides Containing the Inflammation-Associated Marker 3-Nitrotyrosine Evade Central Tolerance and Elicit a Robust Cell-Mediated Immune Response 1 , 2003, The Journal of Immunology.

[7]  C. Boog,et al.  Mass Tag-Assisted Identification of Naturally Processed HLA Class II-Presented Meningococcal Peptides Recognized by CD4+ T Lymphocytes , 2005, The Journal of Immunology.

[8]  A. Rudensky,et al.  In vivo MHC class II presentation of cytosolic proteins revealed by rapid automated tandem mass spectrometry and functional analyses , 2001, European journal of immunology.

[9]  E. Unanue,et al.  Conformational isomers of a peptide–class II major histocompatibility complex , 2005, Immunological reviews.

[10]  R. Holmdahl,et al.  Glycosylation of type II collagen is of major importance for T cell tolerance and pathology in collagen‐induced arthritis , 2002, European journal of immunology.

[11]  E. Unanue,et al.  Identification of the naturally processed form of hen egg white lysozyme bound to the murine major histocompatibility complex class II molecule I-Ak. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[12]  K. Pittois,et al.  cDNA sequence analysis, chromosomal assignment and expression pattern of the gene coding for integral membrane protein 2B. , 1998, Gene.

[13]  A. Sette,et al.  Cutting Edge: The Conversion of Arginine to Citrulline Allows for a High-Affinity Peptide Interaction with the Rheumatoid Arthritis-Associated HLA-DRB1*0401 MHC Class II Molecule1 , 2003, The Journal of Immunology.

[14]  H. Rammensee,et al.  Autophagy promotes MHC class II presentation of peptides from intracellular source proteins , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[15]  William Arbuthnot Sir Lane,et al.  Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles , 1993, The Journal of experimental medicine.

[16]  H. Rammensee,et al.  Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules , 1991, Nature.

[17]  Emil R. Unanue,et al.  In APCs, the Autologous Peptides Selected by the Diabetogenic I-Ag7 Molecule Are Unique and Determined by the Amino Acid Changes in the P9 Pocket1 , 2002, The Journal of Immunology.

[18]  J. Strominger,et al.  HLA-DP2: self peptide sequences and binding properties. , 1997, Journal of immunology.

[19]  M. Davis,et al.  Conformational isomers of a class II MHC-peptide complex in solution. , 1999, Journal of molecular biology.

[20]  William Arbuthnot Sir Lane,et al.  Self-peptides bound to the type I diabetes associated class II MHC molecules HLA-DQ1 and HLA-DQ8. , 1994, International immunology.

[21]  H. Ménard,et al.  Autoantigenic posttranslational modifications of proteins: does it apply to rheumatoid arthritis? , 2002, Current opinion in rheumatology.

[22]  E. Unanue,et al.  Specificity of peptide selection by antigen-presenting cells homozygous or heterozygous for expression of class II MHC molecules: The lack of competition , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[23]  Don C. Wiley,et al.  Structure of a human insulin peptide–HLA-DQ8 complex and susceptibility to type 1 diabetes , 2001, Nature Immunology.

[24]  D. Wiley,et al.  Enhanced Catalytic Action of HLA-DM on the Exchange of Peptides Lacking Backbone Hydrogen Bonds between their N-Terminal Region and the MHC Class II α-Chain1 , 2004, The Journal of Immunology.

[25]  F. Koning,et al.  Dissection of the HLA-DR4 Peptide Repertoire in Endocrine Epithelial Cells: Strong Influence of Invariant Chain and HLA-DM Expression on the Nature of Ligands1 , 2004, The Journal of Immunology.

[26]  F. Koning,et al.  HLA-DR4 Molecules in Neuroendocrine Epithelial Cells Associate to a Heterogeneous Repertoire of Cytoplasmic and Surface Self Peptides1 , 2002, The Journal of Immunology.

[27]  E. Unanue,et al.  Structural basis of peptide binding and presentation by the type I diabetes-associated MHC class II molecule of NOD mice. , 2000, Immunity.

[28]  E. Unanue,et al.  Antigen presentation , 2005, Immunologic research.

[29]  A Sette,et al.  Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad. , 1992, Science.

[30]  G. Nolan,et al.  Interaction of HLA-DR with an acidic face of HLA-DM disrupts sequence-dependent interactions with peptides. , 2003, Immunity.

[31]  E. Jaffee,et al.  Major histocompatibility complex class II‐restricted presentation of a cytosolic antigen by autophagy , 2003, European journal of immunology.

[32]  E. Unanue,et al.  Influence of saccharide size on the cellular immune response to glycopeptides. , 2003, Organic & biomolecular chemistry.

[33]  L. Fugger,et al.  Predominant selection of T cells specific for the glycosylated collagen type II epitope (263–270) in humanized transgenic mice and in rheumatoid arthritis , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[34]  William S. Lane,et al.  Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size , 1992, Nature.

[35]  R. Vierkant,et al.  Identification and Characterization of Novel, Naturally Processed Measles Virus Class II HLA-DRB1 Peptides , 2004, Journal of Virology.

[36]  T. Tuschl,et al.  Endogenous MHC Class II Processing of a Viral Nuclear Antigen After Autophagy , 2005, Science.

[37]  S. Anderton.  Post-translational modifications of self antigens: implications for autoimmunity. , 2004, Current opinion in immunology.

[38]  L. Eisenlohr,et al.  A cytosolic pathway for MHC class II–restricted antigen processing that is proteasome and TAP dependent , 2005, Nature Immunology.

[39]  K. Garcia,et al.  A structural framework for deciphering the link between I-Ag7 and autoimmune diabetes. , 2000, Science.

[40]  H. Rammensee,et al.  Peptide analysis, stability studies, and structural modeling explain contradictory peptide motifs and unique properties of the NOD mouse MHC class II molecule H2‐Ag7 , 2002, European journal of immunology.

[41]  E. Shevach,et al.  Nature of the antigenic complex recognized by T lymphocytes. VII. Evidence for an association between TNP-conjugated macrophage membrane components and Ia antigens. , 1978, Journal of immunology.

[42]  E. Unanue,et al.  Activated antigen-presenting cells select and present chemically modified peptides recognized by unique CD4 T cells , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[43]  A. Rudensky,et al.  Sequence analysis of peptides bound to MHC class II molecules , 1991, Nature.

[44]  R. Doebele,et al.  Determination of the HLA-DM interaction site on HLA-DR molecules. , 2000, Immunity.

[45]  E. Unanue,et al.  T cells distinguish MHC-peptide complexes formed in separate vesicles and edited by H2-DM. , 2004, Immunity.

[46]  Charles A. Janeway,et al.  Altered positive selection due to corecognition of floppy peptide/MHC II conformers supports an integrative model of thymic selection , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[47]  Delu Zhou,et al.  Lamp-2a facilitates MHC class II presentation of cytoplasmic antigens. , 2005, Immunity.

[48]  E. Unanue,et al.  Cutting Edge: H-2DM Is Responsible for the Large Differences in Presentation Among Peptides Selected by I-Ak During Antigen Processing 1 , 2003, The Journal of Immunology.

[49]  V. Crotzer,et al.  Autophagy and intracellular surveillance: Modulating MHC class II antigen presentation with stress , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[50]  S. Leskowitz,et al.  Role of the Carrier in Development of Delayed Sensitivity to the Azophenyl-Arsonate Group , 1965, Nature.

[51]  J. Todd,et al.  HLA-DQβ gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus , 1987, Nature.

[52]  E. Unanue,et al.  Distinct recognition by two subsets of T cells of an MHC class II-peptide complex , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[53]  C. Locht,et al.  Methylation-dependent T cell immunity to Mycobacterium tuberculosis heparin-binding hemagglutinin , 2004, Nature Medicine.